Cargando…
Radiotherapy for T1N0M0 Esophageal Cancer: Analyses of the Predictive Factors and the Role of Endoscopic Submucosal Dissection in the Local Control
Several therapeutic options are available for clinical T1N0M0 thoracic esophageal squamous cell carcinoma (stage I ESCC); however, the studies on the treatment results are limited. This study assessed the outcomes of stage I ESCC treated with radiotherapy (RT), determined predictive factors, and eva...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115973/ https://www.ncbi.nlm.nih.gov/pubmed/30081489 http://dx.doi.org/10.3390/cancers10080259 |
_version_ | 1783351504412868608 |
---|---|
author | Suzuki, Gen Yamazaki, Hideya Aibe, Norihiro Masui, Koji Shimizu, Daisuke Kimoto, Takuya Nishimura, Takeshi Nakashima, Akihiro Takenaka, Tadashi Dohi, Osamu Ishikawa, Takeshi Yamada, Kei |
author_facet | Suzuki, Gen Yamazaki, Hideya Aibe, Norihiro Masui, Koji Shimizu, Daisuke Kimoto, Takuya Nishimura, Takeshi Nakashima, Akihiro Takenaka, Tadashi Dohi, Osamu Ishikawa, Takeshi Yamada, Kei |
author_sort | Suzuki, Gen |
collection | PubMed |
description | Several therapeutic options are available for clinical T1N0M0 thoracic esophageal squamous cell carcinoma (stage I ESCC); however, the studies on the treatment results are limited. This study assessed the outcomes of stage I ESCC treated with radiotherapy (RT), determined predictive factors, and evaluated the benefits of endoscopic submucosal dissection (ESD) combined with RT. We retrospectively analyzed the data of 50 patients (41 men, 9 women; median age, 66 years) with stage I ESCC treated with RT. The median total irradiation dose was 50 Gy. Elective nodal irradiation (ENI) was performed in 17 patients and ESD in 29 patients (ESD group). Forty-six patients concurrently received chemotherapy with RT. The median tumor length of ESD and non-ESD groups was 2.3 and 5 cm, respectively. The median follow-up was 33 months. The 3-year overall survival, disease-free survival (DFS), and local control (LC) rates were 77.3%, 61.1%, and 88.1%, respectively. Grade 3 adverse events occurred in 14 patients. T stage and tumor length were significant prognostic factors for 3-year DFS and 3-year LC, respectively. ESD appeared to be an important prognostic factor for LC. ENI and total irradiation dose above 50.4 Gy were not predictive factors. Our findings might help in treatment decisions for stage I ESCC. |
format | Online Article Text |
id | pubmed-6115973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61159732018-08-31 Radiotherapy for T1N0M0 Esophageal Cancer: Analyses of the Predictive Factors and the Role of Endoscopic Submucosal Dissection in the Local Control Suzuki, Gen Yamazaki, Hideya Aibe, Norihiro Masui, Koji Shimizu, Daisuke Kimoto, Takuya Nishimura, Takeshi Nakashima, Akihiro Takenaka, Tadashi Dohi, Osamu Ishikawa, Takeshi Yamada, Kei Cancers (Basel) Article Several therapeutic options are available for clinical T1N0M0 thoracic esophageal squamous cell carcinoma (stage I ESCC); however, the studies on the treatment results are limited. This study assessed the outcomes of stage I ESCC treated with radiotherapy (RT), determined predictive factors, and evaluated the benefits of endoscopic submucosal dissection (ESD) combined with RT. We retrospectively analyzed the data of 50 patients (41 men, 9 women; median age, 66 years) with stage I ESCC treated with RT. The median total irradiation dose was 50 Gy. Elective nodal irradiation (ENI) was performed in 17 patients and ESD in 29 patients (ESD group). Forty-six patients concurrently received chemotherapy with RT. The median tumor length of ESD and non-ESD groups was 2.3 and 5 cm, respectively. The median follow-up was 33 months. The 3-year overall survival, disease-free survival (DFS), and local control (LC) rates were 77.3%, 61.1%, and 88.1%, respectively. Grade 3 adverse events occurred in 14 patients. T stage and tumor length were significant prognostic factors for 3-year DFS and 3-year LC, respectively. ESD appeared to be an important prognostic factor for LC. ENI and total irradiation dose above 50.4 Gy were not predictive factors. Our findings might help in treatment decisions for stage I ESCC. MDPI 2018-08-03 /pmc/articles/PMC6115973/ /pubmed/30081489 http://dx.doi.org/10.3390/cancers10080259 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Suzuki, Gen Yamazaki, Hideya Aibe, Norihiro Masui, Koji Shimizu, Daisuke Kimoto, Takuya Nishimura, Takeshi Nakashima, Akihiro Takenaka, Tadashi Dohi, Osamu Ishikawa, Takeshi Yamada, Kei Radiotherapy for T1N0M0 Esophageal Cancer: Analyses of the Predictive Factors and the Role of Endoscopic Submucosal Dissection in the Local Control |
title | Radiotherapy for T1N0M0 Esophageal Cancer: Analyses of the Predictive Factors and the Role of Endoscopic Submucosal Dissection in the Local Control |
title_full | Radiotherapy for T1N0M0 Esophageal Cancer: Analyses of the Predictive Factors and the Role of Endoscopic Submucosal Dissection in the Local Control |
title_fullStr | Radiotherapy for T1N0M0 Esophageal Cancer: Analyses of the Predictive Factors and the Role of Endoscopic Submucosal Dissection in the Local Control |
title_full_unstemmed | Radiotherapy for T1N0M0 Esophageal Cancer: Analyses of the Predictive Factors and the Role of Endoscopic Submucosal Dissection in the Local Control |
title_short | Radiotherapy for T1N0M0 Esophageal Cancer: Analyses of the Predictive Factors and the Role of Endoscopic Submucosal Dissection in the Local Control |
title_sort | radiotherapy for t1n0m0 esophageal cancer: analyses of the predictive factors and the role of endoscopic submucosal dissection in the local control |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115973/ https://www.ncbi.nlm.nih.gov/pubmed/30081489 http://dx.doi.org/10.3390/cancers10080259 |
work_keys_str_mv | AT suzukigen radiotherapyfort1n0m0esophagealcanceranalysesofthepredictivefactorsandtheroleofendoscopicsubmucosaldissectioninthelocalcontrol AT yamazakihideya radiotherapyfort1n0m0esophagealcanceranalysesofthepredictivefactorsandtheroleofendoscopicsubmucosaldissectioninthelocalcontrol AT aibenorihiro radiotherapyfort1n0m0esophagealcanceranalysesofthepredictivefactorsandtheroleofendoscopicsubmucosaldissectioninthelocalcontrol AT masuikoji radiotherapyfort1n0m0esophagealcanceranalysesofthepredictivefactorsandtheroleofendoscopicsubmucosaldissectioninthelocalcontrol AT shimizudaisuke radiotherapyfort1n0m0esophagealcanceranalysesofthepredictivefactorsandtheroleofendoscopicsubmucosaldissectioninthelocalcontrol AT kimototakuya radiotherapyfort1n0m0esophagealcanceranalysesofthepredictivefactorsandtheroleofendoscopicsubmucosaldissectioninthelocalcontrol AT nishimuratakeshi radiotherapyfort1n0m0esophagealcanceranalysesofthepredictivefactorsandtheroleofendoscopicsubmucosaldissectioninthelocalcontrol AT nakashimaakihiro radiotherapyfort1n0m0esophagealcanceranalysesofthepredictivefactorsandtheroleofendoscopicsubmucosaldissectioninthelocalcontrol AT takenakatadashi radiotherapyfort1n0m0esophagealcanceranalysesofthepredictivefactorsandtheroleofendoscopicsubmucosaldissectioninthelocalcontrol AT dohiosamu radiotherapyfort1n0m0esophagealcanceranalysesofthepredictivefactorsandtheroleofendoscopicsubmucosaldissectioninthelocalcontrol AT ishikawatakeshi radiotherapyfort1n0m0esophagealcanceranalysesofthepredictivefactorsandtheroleofendoscopicsubmucosaldissectioninthelocalcontrol AT yamadakei radiotherapyfort1n0m0esophagealcanceranalysesofthepredictivefactorsandtheroleofendoscopicsubmucosaldissectioninthelocalcontrol |